Substance K: Vascular and cardiac effects in rat and pig

[1]  G. Feuerstein,et al.  Bombesin and substance P modulate peripheral sympathetic and cardiovascular activity , 1985, Peptides.

[2]  T. O'donohue,et al.  Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor. , 1984, Science.

[3]  J. Hunter,et al.  A pharmacological study with substance K: evidence for multiple types of tachykinin receptors. , 1984, European journal of pharmacology.

[4]  J. Glowinski,et al.  A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. , 1984, Molecular pharmacology.

[5]  J. Glowinski,et al.  Neuromedin K, a tool to further distinguish two central tachykinin binding sites. , 1984, European journal of pharmacology.

[6]  J. Maggio,et al.  The autoradiographic distribution of kassinin and substance K binding sites is different from the distribution of substance P binding sites in rat brain. , 1984, European journal of pharmacology.

[7]  C. Pilapil,et al.  Comparative potencies of substance P, substance K and neuromedin K on brain substance P receptors , 1984, Neuropeptides.

[8]  H. Nawa,et al.  Substance K: a novel mammalian tachykinin that differs from substance P in its pharmacological profile. , 1984, Life sciences.

[9]  E. Escher,et al.  Receptors for substance P. III. Classification by competitive antagonists. , 1984, European journal of pharmacology.

[10]  E. Escher,et al.  Receptors for substance P. I. The pharmacological preparations. , 1984, European journal of pharmacology.

[11]  J. Hunter,et al.  Pharmacological characterisation of a novel tachykinin isolated from mammalian spinal cord. , 1984, European journal of pharmacology.

[12]  S. Nakanishi,et al.  Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor , 1983, Nature.

[13]  G. Feuerstein,et al.  Coronary constriction by leukotriene C4, D4, and E4 in the intact pig heart. , 1983, The American journal of cardiology.

[14]  I. Kanazawa,et al.  Novel Neuropeptides, Neurokinin α and β, Isolated from Porcine Spinal Cord , 1983 .

[15]  M. Petty,et al.  The cardiovascular effects of centrally administered substance P in the anaesthetised rabbit. , 1982, European journal of pharmacology.

[16]  M. Costa,et al.  Substance P-like immunoreactivity in nerves associated with the vascular system of guinea-pigs , 1982, Neuroscience.

[17]  D. Garver,et al.  Monoamine distribution in primate brain—IV. Indoleamine-containing perikarya in the brain stem of Macaca arctoides , 1982, Neuroscience.

[18]  R. Couture,et al.  Mini review: smooth muscle pharmacology of substance P. , 1982, Pharmacology.

[19]  I. Kopin,et al.  Plasma catecholamine and blood pressure responses to sympathetic stimulation in pithed rats. , 1979, The American journal of physiology.

[20]  I. Kopin,et al.  Assay of cathecholamines in human plasma: studies of a single isotope radioenzymatic procedure. , 1976, Life sciences.

[21]  M. da Prada,et al.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. , 1976, Life sciences.

[22]  J. Gillespie,et al.  A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. , 1967, British journal of pharmacology and chemotherapy.

[23]  A. Barger,et al.  SIMPLIFIED TECHNIQUE FOR CHRONIC CATHETERIZATION OF BLOOD VESSELS. , 1964, Journal of applied physiology.